SCHEMBL23187530

SCHEMBL23187530

CCNc1nc(N)c(C=N)c(Nc2ccccc2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ MAPK1 P28482 4/20 0.39
▸ MAPT P10636 2/20 0.39
▸ APP P05067 2/20 0.39
▸ BCHE P06276 2/20 0.39
▸ ACHE P22303 2/20 0.39
▸ PKM P14618 2/20 0.39
▸ KCNH3 Q9ULD8 2/20 0.39
▸ CDK5 Q00535 1/20 0.39
▸ CDK5R1 Q15078 1/20 0.39
▸ TP53 P04637 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14065506 0.71 KCNH3 (0.58) L3MBTL1NPC1RAB9ACYP1A2CYP2C19
SCHEMBL301484 0.68 EGFR (0.57) CDK5
SCHEMBL14117997 0.66 PKM (0.58) L3MBTL1CYP1A2CYP2C19PKMKCNH3
Aniline SCHEMBL28092387 0.66 PKM (0.50) L3MBTL1NPC1RAB9ACYP1A2CYP2C19
SCHEMBL12421837 0.65 MEN1 (0.73) L3MBTL1NPC1RAB9ACYP1A2CYP2C19
SCHEMBL11318927 0.65 MAPT (0.57) L3MBTL1NPC1RAB9ACYP1A2CYP2C19
SCHEMBL14117985 0.64 FCGR3B (0.54) L3MBTL1NPC1RAB9ACYP1A2CYP2C19
SCHEMBL31149853 0.64 FCGR3B (0.54) L3MBTL1NPC1RAB9ACYP1A2CYP2C19
SCHEMBL16929572 0.64 PKM (0.49) L3MBTL1NPC1RAB9ACYP1A2CYP2C19
SCHEMBL24701332 0.63 CA1 (0.36) CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3800188-A1 SUBSTITUTED PYRAZOLOPYRIMIDINES AS IRAK4 INHIBITORS Bayer AG (DE) 2021-04-07 — — EP disclosed
Send feedback